SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001140361-21-016389
Filing Date
2021-05-07
Accepted
2021-05-07 13:01:01
Documents
1
Group Members
COREY GOODMANROBERT ADELMANVENBIO GLOBAL STRATEGIC GP II, L.P.VENBIO GLOBAL STRATEGIC GP II, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G brhc10024072_sc13g.htm SC 13G 186939
  Complete submission text file 0001140361-21-016389.txt   188629
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Subject) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92517 | Film No.: 21901473
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund II L.P. (Filed by) CIK: 0001634632 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G